• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算机的研究:HLA 异质性对不同种族人群针对 SARS-CoV-2 的 CTL 反应的影响。

In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2.

机构信息

Department of Biochemistry, Indian Institute of Science, Bangalore, India.

Department of Biochemistry, Indian Institute of Science, Bangalore, India; Center for BioSystems Science and Engineering (BSSE), Indian Institute of Science, Bangalore, India.

出版信息

Hum Immunol. 2022 Dec;83(12):797-802. doi: 10.1016/j.humimm.2022.09.008. Epub 2022 Oct 11.

DOI:10.1016/j.humimm.2022.09.008
PMID:36229378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9550298/
Abstract

Differences in outcome to COVID-19 infection in different individuals is largely attributed to genetic heterogeneity leading to differential immune responses across individuals and populations. HLA is one such genetic factor that varies across individuals leading to differences in how T-cell responses are triggered against SARS-CoV-2, directly influencing disease susceptibility. HLA alleles that influence COVID-19 outcome, by virtue of epitope binding and presentation, have been identified in cohorts worldwide. However, the heterogeneity in HLA distribution across ethnic groups limits the generality of such association. In this study, we address this limitation by comparing the recognition of CTL epitopes across HLA genotypes and ethnic groups. Using HLA allele frequency data for ethnic groups from Allele Frequency Net Database (AFND), we construct synthetic populations for each ethnic group and show that CTL epitope strength varies across HLA genotypes and populations. We also observe that HLA genotypes, in certain cases, can have high CTL epitope strengths in the absence of top-responsive HLA alleles. Finally, we show that the theoretical estimate of responsiveness and hence protection offered by a HLA allele is bound to vary across ethnic groups, due to the influence of other HLA alleles within the HLA genotype on CTL epitope recognition. This emphasizes the need for studying HLA-disease associations at the genotype level rather than at a single allele level.

摘要

个体间对 COVID-19 感染的结果差异主要归因于遗传异质性,导致个体和人群间的免疫反应存在差异。HLA 就是这样一种遗传因素,它在个体间存在差异,导致针对 SARS-CoV-2 的 T 细胞反应的触发方式不同,直接影响疾病易感性。通过表位结合和呈递,已在全球队列中鉴定出影响 COVID-19 结局的 HLA 等位基因。然而,不同种族群体中 HLA 分布的异质性限制了这种关联的普遍性。在这项研究中,我们通过比较跨 HLA 基因型和种族群体的 CTL 表位识别来解决这一限制。使用来自 Allele Frequency Net Database (AFND) 的种族群体的 HLA 等位基因频率数据,我们为每个种族群体构建了合成群体,并表明 CTL 表位强度在 HLA 基因型和人群中存在差异。我们还观察到,在某些情况下,即使没有高反应性的 HLA 等位基因,HLA 基因型也可以具有高 CTL 表位强度。最后,我们表明,由于 HLA 基因型内其他 HLA 等位基因对 CTL 表位识别的影响,HLA 等位基因提供的理论估计的反应性和因此提供的保护必然会因种族群体而异。这强调了需要在基因型水平而不是单个等位基因水平上研究 HLA-疾病关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec2/9550298/0442a007e525/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec2/9550298/61c76c17ad45/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec2/9550298/0442a007e525/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec2/9550298/61c76c17ad45/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec2/9550298/0442a007e525/gr2_lrg.jpg

相似文献

1
In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2.基于计算机的研究:HLA 异质性对不同种族人群针对 SARS-CoV-2 的 CTL 反应的影响。
Hum Immunol. 2022 Dec;83(12):797-802. doi: 10.1016/j.humimm.2022.09.008. Epub 2022 Oct 11.
2
Pressured cytotoxic T cell epitope strength among SARS-CoV-2 variants correlates with COVID-19 severity.在 SARS-CoV-2 变体中,受压细胞毒性 T 细胞表位强度与 COVID-19 严重程度相关。
HLA. 2023 Oct;102(4):464-476. doi: 10.1111/tan.15071. Epub 2023 May 3.
3
Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?不同种族人群对 SARS-CoV2 表位的免疫识别是否存在差异?
Virus Res. 2021 Nov;305:198579. doi: 10.1016/j.virusres.2021.198579. Epub 2021 Sep 21.
4
A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.一种基于蛋白质组学的免疫信息学工具,用于加速新兴传染病背景下的 T 细胞表位发现和疫苗设计:一种面向种族的方法。
Front Immunol. 2021 Feb 26;12:598778. doi: 10.3389/fimmu.2021.598778. eCollection 2021.
5
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.基于全球人群中 HLA Ⅰ类基因座(HLA-A、-B、-C)分布的 COVID-19 冠状病毒疫苗 T 细胞表位预测分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11.
6
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.鉴定 SARS-CoV-2 蛋白在南美的新型候选表位:按国家/地区分析 HLA 频率的综述。
Front Immunol. 2020 Sep 3;11:2008. doi: 10.3389/fimmu.2020.02008. eCollection 2020.
7
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades.对肯尼亚一组人群进行的人类白细胞抗原(HLA)分型鉴定出了新的I类等位基因,这些等位基因限制了细胞毒性T细胞对当地HIV-1进化枝的反应。
AIDS. 2002 Sep 27;16(14):1899-904. doi: 10.1097/00002030-200209270-00006.
8
HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.针对免疫显性最佳表位的HIV-1特异性细胞毒性T淋巴细胞(CTL)反应减缓了中国艾滋病的进展。
Curr HIV Res. 2008 Jun;6(4):335-50. doi: 10.2174/157016208785132473.
9
Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes.HLA I类分子限制性细胞毒性T淋巴细胞表位的人群覆盖率。
Immunogenetics. 2001;52(3-4):165-73. doi: 10.1007/s002510000271.
10
HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.HLA 超型在 HIV-1 Nef 和 Gag 蛋白的细胞毒性 T 淋巴细胞表位聚类中发挥作用。
AIDS Res Hum Retroviruses. 2013 Feb;29(2):270-8. doi: 10.1089/AID.2012.0160. Epub 2013 Jan 8.

引用本文的文献

1
Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults.老年人接种新冠mRNA疫苗及突破性感染后的T细胞反应动态
Pathog Immun. 2023 Nov 17;8(1):117-135. doi: 10.20411/pai.v8i1.613. eCollection 2023.

本文引用的文献

1
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.SARS-CoV-2 易感性和 COVID-19 疾病严重程度与影响各种组织中基因表达的遗传变异有关。
Cell Rep. 2021 Nov 16;37(7):110020. doi: 10.1016/j.celrep.2021.110020. Epub 2021 Nov 3.
2
Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?不同种族人群对 SARS-CoV2 表位的免疫识别是否存在差异?
Virus Res. 2021 Nov;305:198579. doi: 10.1016/j.virusres.2021.198579. Epub 2021 Sep 21.
3
The Association of Human Leukocyte Antigen and COVID-19 in Southern China.
中国南方人类白细胞抗原与新型冠状病毒肺炎的关联
Open Forum Infect Dis. 2021 Aug 6;8(9):ofab410. doi: 10.1093/ofid/ofab410. eCollection 2021 Sep.
4
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.HLA-C*04:01携带者感染新型冠状病毒肺炎后出现严重临床病程的风险增加。
EClinicalMedicine. 2021 Oct;40:101099. doi: 10.1016/j.eclinm.2021.101099. Epub 2021 Sep 2.
5
Immunological lessons from genome-wide association studies of infections.从全基因组关联研究看感染的免疫学教训。
Curr Opin Immunol. 2021 Oct;72:87-93. doi: 10.1016/j.coi.2021.03.017. Epub 2021 Apr 18.
6
HLA, Immune Response, and Susceptibility to COVID-19.人类白细胞抗原、免疫反应与 COVID-19 易感性。
Front Immunol. 2021 Jan 8;11:601886. doi: 10.3389/fimmu.2020.601886. eCollection 2020.
7
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies.人口统计学因素与 COVID-19 感染、严重程度、重症监护病房入院和死亡的关系:59 项研究的荟萃分析。
BMJ Open. 2021 Jan 11;11(1):e044640. doi: 10.1136/bmjopen-2020-044640.
8
Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants.职业与重症新型冠状病毒肺炎风险:对120075名英国生物银行参与者的前瞻性队列研究
Occup Environ Med. 2020 Dec 9;78(5):307-14. doi: 10.1136/oemed-2020-106731.
9
Epitope prediction and identification- adaptive T cell responses in humans.表位预测和鉴定——人类适应性 T 细胞反应。
Semin Immunol. 2020 Aug;50:101418. doi: 10.1016/j.smim.2020.101418. Epub 2020 Oct 31.
10
Comorbidity and its Impact on Patients with COVID-19.合并症及其对COVID-19患者的影响。
SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.